Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Lorus Therapeutics (LRP)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for LRP as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
INCOME STATEMENT (
See all
)
Revenue
►
17K
VERY LOW
EBITDA
►
-897K
VERY HIGH
Net Income
►
-6.16M
HIGH
Revenue Growth
►
-85.1%
LOW
Operating Margin
►
-47488.2%
VERY LOW
Net Margin
►
-36223.5%
VERY LOW
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-6.08
Current Ratio
►
5.10
AVG
Quick Ratio
►
5.10
AVG
Interest Coverage Ratio
►
-1.15
HIGH
Book Value Per Share
►
-0.00966
Cash Per Share
►
0.0273
Loading...
STOCK SUMMARY
No data.
VALUATION
Price to Earnings (P/E)
►
-2.02
Price to Book (P/B)
►
-5.18
Price to Sales (P/S)
►
730
HIGH
Return on Assets (ROA)
►
-33.9%
HIGH
Return on Equity (ROE)
►
-506%
LOW
EV/EBITDA
►
-35.1
Dividend Yield
0%
AVG
OWNERSHIP
No data.
No Sales Breakout Data.